Core One Labs Applauds TheraPsil on Its Submission to Health Canada

VANCOUVER, British Columbia, Aug. 15, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt:…

Core One Labs’ Clinics Submit Application to Treat Patient With Psilocybin Psychedelic-Assisted Therapy

VANCOUVER, British Columbia, Aug. 13, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt:…

Core One Labs’ Virtual Town Hall Reveals Company is Nearing Production of Biosynthesized Psilocybin: Breakthrough In the Psychedelic Space Expected Upon Successful Completion

VANCOUVER, British Columbia, Aug. 04, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt:…

Core One Labs’ Akome Seeks to Revolutionize Treatment of Parkinson’s Disease and Submits Application to Protect IP

VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt:…

Core One Labs’ Akome Biotech Protects New AKO003 Ketamine-Based Breakthrough Drug Formulation For Depression Treatment

VANCOUVER, British Columbia, July 21, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL) (OTC: CLABD) (Frankfurt:…

Core One Labs Announces Details of Consolidation to Meet Nasdaq Listing Requirements

VANCOUVER, British Columbia, July 16, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU)…

New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

VANCOUVER, British Columbia, June 19, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs Retains Canada’s Highest-Ranked IP Law Firm to Assist With Patent Filings

VANCOUVER, British Columbia, June 18, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs Plans Share Consolidation in Preparation of Listing its Common Shares on Nasdaq

VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC:…

Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent

VANCOUVER, British Columbia, June 12, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease

VANCOUVER, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

World Renowned Physician Joins Core One Labs as Chief Medical Officer

VANCOUVER, British Columbia, May 05, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…